BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2015
View Archived Issues
ProMetic partners with ProThera to develop plasma-derived IAIP
Read More
Spring Bank plans phase II trial of SB-9200 and Viread in HBV infection
Read More
University of Adelaide to conduct phase I study of AmpliPhi's AB-SA01
Read More
Galapagos begins phase I study of GLPG-1972
Read More
Daiichi Sankyo doses first subject in phase I study using Anticalin technology
Read More
Boston Pharmaceuticals launched to develop drugs for complex diseases
Read More
Autologous CBL-B-silenced cell therapy is feasible in patients with solid tumors
Read More
MediciNova to begin phase IIa study of MN-001 for hypertriglyceridemia in patients with NASH
Read More
Phase Ib trial of Aptose's APTO-253 placed on hold
Read More
Immune responses, survival improvements seen with uveal melanoma DC vaccine
Read More
Benepali is first biosimilar etanercept recommended for approval in E.U.
Read More
Vitamin D analogue DP-001 may be superior for treating secondary hyperparathyroidism
Read More
First preclinical results presented for a novel, noncovalent BTK inhibitor
Read More
CHMP recommends approval of Briviact
Read More
AstraZeneca patents ATM kinase inhibitors
Read More
Kineta discloses antiviral RIG-I pathway modulators
Read More
Bristol-Myers Squibb reports GPR40 modulators
Read More
U.S. Department of Health & Human Services introduces CB1 receptor ligands
Read More
Merck KGaA patents PARP-1/TNKS inhibitors
Read More
NEO-214 shows efficacy against gliomas
Read More
AstraZeneca sells U.S. rights to Entocort to Perrigo
Read More
Pharmacological chaperone shows promise for GM1 and Morquio B lysosomal diseases
Read More
CHMP recommends approval of Episalvan to treat partial thickness wounds in adults
Read More
Metastatic colorectal cancer study shows administration of neratinib with cetuximab is feasible
Read More
FDA clears IND for phase IIa trial of Generon's F-652 for alcoholic hepatitis
Read More
FDA approves Opdivo for renal cell carcinoma
Read More
European Commission approves Elocta for hemophilia A
Read More
European Comission grants two landmark approvals to Novartis' Consentyx
Read More
European Commission gives conditional marketing authorization to Blincyto
Read More
Gilead Sciences' Genvoya approved in E.U. for HIV-1 infection
Read More